| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/26/2006 | WO2006010150A2 Housekeeping genes and methods for identifying the same |
| 01/26/2006 | WO2006010051A2 Methods of diagnosing & treating diabetes and insulin resistance |
| 01/26/2006 | WO2006010038A2 Inducible fluorescence assay |
| 01/26/2006 | WO2006010033A2 Detection of nucleic acids to assess risk for bovine spongiform encephalopathy |
| 01/26/2006 | WO2006009962A2 Acacs as modifiers of the igf pathway and methods of use |
| 01/26/2006 | WO2006009947A2 Migfs as modifiers of the igf pathway and methods of use |
| 01/26/2006 | WO2006009933A2 Cdk9 as modifier of the igf pathway and methods of use |
| 01/26/2006 | WO2006009880A2 Identifying virally infected and vaccinated organisms |
| 01/26/2006 | WO2006009870A2 Compositions and methods for preventing carry-over contamination in nucleic acid amplification reactions |
| 01/26/2006 | WO2006009860A2 Methods for identifying stem cells based on nuclear morphotypes |
| 01/26/2006 | WO2006009702A2 Liver disease-related methods and systems |
| 01/26/2006 | WO2006009260A1 Method of detecting hepatitis e virus |
| 01/26/2006 | WO2006009241A1 Lrp4/CORIN DOPAMINE-PRODUCING NEURON PRECURSOR CELL MARKER |
| 01/26/2006 | WO2006008656A2 Oatp-c gene c463a polymorphism underlies variable response of statin therapy |
| 01/26/2006 | WO2006008650A2 Dna methylation in the assessment of leukemia |
| 01/26/2006 | WO2006008632A2 Novel allelic variant of cyp2c19 associated with drug metabolism |
| 01/26/2006 | WO2006008575A2 Construction of a comparative database and identificaiton of virulence factors through comparison of polymorphic regions in clinical isolates of infectious organisms |
| 01/26/2006 | WO2006008526A2 Method of predicting the responsiveness oa a tumor to erbb receptor drugs |
| 01/26/2006 | WO2006008479A1 A method for performing the hot start of enzymatic reactions |
| 01/26/2006 | WO2006008342A1 Method for detecting the risk of and for treatment of type 2 diabetes |
| 01/26/2006 | WO2006008267A2 Methods for optimizing forming viiia-based hemostatic treatment |
| 01/26/2006 | WO2006008142A1 Diagnosis and therapy of psoriasis vulgaris |
| 01/26/2006 | WO2006008128A2 Epigenetic methods and nucleic acids for the detection of breast cell proliferative disorders |
| 01/26/2006 | WO2006008126A2 Novel use of the kinases rsk4 and pak5 |
| 01/26/2006 | WO2006008124A2 Molecular diagnostic method and treatment in dementia with lewy bodies |
| 01/26/2006 | WO2006008098A2 P1-34 expression units with corynebacterium glutamicum |
| 01/26/2006 | WO2006008088A2 Secretory phospholipase a2 (spla2) as prognostic and diagnostic marker for cardiovascular diseases |
| 01/26/2006 | WO2006008007A2 Diagnostics and therapeutics for diseases associated with retinoid-inducible serine carboxypeptidase (risc) |
| 01/26/2006 | WO2006008002A2 Diagnostics and therapeutics for diseases associated with kallikrein 1 (klk1) |
| 01/26/2006 | WO2006007981A1 Active substances for increasing pathogenic defence in plants and methods for the detection thereof |
| 01/26/2006 | WO2006007980A2 Esr1 and cervical cancer |
| 01/26/2006 | WO2006007937A1 Methods and assays for detecting guanylate cyclase activity |
| 01/26/2006 | WO2006007869A1 Monitoring heart failure |
| 01/26/2006 | WO2006007853A2 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line |
| 01/26/2006 | WO2006007751A2 Metabolic method to identify flavours and/or fragrances |
| 01/26/2006 | WO2005118809A3 Methods and compositions for enhancing cell adhesion properties |
| 01/26/2006 | WO2005111242A3 Digital profiling of polynucleotide populations |
| 01/26/2006 | WO2005102396A3 Multimodality nanostructures, methods of fabrication thereof, and methods of use thereof |
| 01/26/2006 | WO2005098019A3 Method and device for testing the bactericidal effect of substances |
| 01/26/2006 | WO2005086891A9 Classification of breast cancer patients using a combination of clinical criteria and informative genesets |
| 01/26/2006 | WO2005086595A3 Telomere protein trf2 dna-binding domain mutant protein, telomere dna mutant and utilization of complex structure of trf2 dna-binding domain with double-stranded dna |
| 01/26/2006 | WO2005082398A3 Diagnosis of hyperinsulinemia and type ii diabetes and protection against same based on genes differentially expressed in muscle cells |
| 01/26/2006 | WO2005080565A8 Dna array for analyzing dna methylation, method of constructing the same and mehtod of analyzing dna methylaion |
| 01/26/2006 | WO2005079458A3 ENHANCEMENT OF Th2-DEPENDENT AND INFLAMMATORY RESPONSE |
| 01/26/2006 | WO2005079316A3 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
| 01/26/2006 | WO2005055808A3 Compositions and methods to diagnose and treat lung cancer |
| 01/26/2006 | WO2005049817A3 Self-cleaving ribozymes and uses thereof |
| 01/26/2006 | WO2005027727A3 Use of pin1 inhibitors for treatment of cancer |
| 01/26/2006 | WO2005017119A3 Ups as modifiers of the beta catenin pathway and methods of use |
| 01/26/2006 | WO2005017109A3 Nucleic acids and polypeptides required for cell survival in the absence of rb |
| 01/26/2006 | WO2005012872A3 Liquid crystal based analyte detection |
| 01/26/2006 | WO2005005647A3 Compositions, splice variants and methods relating to ovarian specific genes and proteins |
| 01/26/2006 | WO2004113502A3 Identification of therapeutic agents using genetic fingerprinting |
| 01/26/2006 | WO2004076636A3 A novel human g-protein coupled receptor, hgprbmy23, expressed highly in kidney |
| 01/26/2006 | WO2004045532A3 Methods for preventing and treating cancer metastasis and bone loss associated with cancer metastasis |
| 01/26/2006 | WO2004033669A3 Methods of manipulating nucleic acids |
| 01/26/2006 | WO2004014319A3 Screening strategy for anticancer drugs |
| 01/26/2006 | WO2004013160A3 Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof |
| 01/26/2006 | WO2002063032A9 Methods and kits for identifying scavengers of reactive oxygen species (ros) |
| 01/26/2006 | US20060021076 Prenatal screening |
| 01/26/2006 | US20060020439 System and method for discovering gene regulatory models and genetic networks using relational fuzzy models |
| 01/26/2006 | US20060020399 Method of mapping cDNA sequences |
| 01/26/2006 | US20060020391 Method for tracking and controlling infections |
| 01/26/2006 | US20060020119 Monoclonal antibodies to gastrin hormone |
| 01/26/2006 | US20060020114 Apo-2DcR |
| 01/26/2006 | US20060020113 Human Six Transmembrane Epithelial Antigen of the Prostate (STEAP) protein; folds in a "serpentine" manner into three extracellular and two intracellular loops; used for diagnosis and treatment of prostate cancer |
| 01/26/2006 | US20060020110 Synthetic peptides that bind to the hepatitis B virus core and E antigens |
| 01/26/2006 | US20060019924 used in neuroblastoma therapy and diagnosis |
| 01/26/2006 | US20060019918 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 01/26/2006 | US20060019915 Method to modulate the immune system with a novel guanine nucleotide exchange factor |
| 01/26/2006 | US20060019911 Drug-carrier complexes and methods of use thereof |
| 01/26/2006 | US20060019910 Inhibiting c Jun amino terminal kinase signal transduction pathway; reducing tumor necrosis factor alpha induced lipolysis |
| 01/26/2006 | US20060019909 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 01/26/2006 | US20060019895 Using soluble frizzled related protein 3 (SFRP-3) and/or Dickkopf-1 (DKK1) expression profiles as evaluative tools in prediciting/diagnosing bone disorders in cancer patients |
| 01/26/2006 | US20060019879 Polynucleotide encoding autoantigens associated with endometriosis |
| 01/26/2006 | US20060019878 Polynucleotide encoding autoantigens associated with endometriosis |
| 01/26/2006 | US20060019405 Cat lavator comprising an urine test |
| 01/26/2006 | US20060019392 Novel bone mineralization proteins, DNA, vectors, expression systems |
| 01/26/2006 | US20060019383 Chemical inhibitors of mismatch repair |
| 01/26/2006 | US20060019373 Biosensor with rf signal transmission |
| 01/26/2006 | US20060019366 Reversibly modified thermostable enzyme compositions and methods of making and using the same |
| 01/26/2006 | US20060019365 IKK-alpha proteins, nucleic acids and methods |
| 01/26/2006 | US20060019353 Protein-nucleic acid conjugate for producing specific nucleic acid |
| 01/26/2006 | US20060019349 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 01/26/2006 | US20060019345 Human GABAb receptor 1 promoters |
| 01/26/2006 | US20060019331 Method and system for generating a telephone alert indicating the presence of an analyte |
| 01/26/2006 | US20060019330 Combining test sample and the Staphylococcus aureus reactant wherein the test sample results in a change of at least one physical property detectable by a horizontal surface acoustical wave biosensor if Staphylococcus aureus is present; detecting change with the shear horizontal surface wave biosensor |
| 01/26/2006 | US20060019329 Method of screening for protein inhibitors and activators |
| 01/26/2006 | US20060019328 Glucose dehydrogenase |
| 01/26/2006 | US20060019327 coating membrane system over non-planar continuous strand by serially depositing plurality of layers to form membrane system which comprises a membrane layer configured to control a flux of an analyte and an enzyme domain layer comprising an enzyme for reacting with the analyte |
| 01/26/2006 | US20060019326 evaluation carried out in three-dimensional tissue-engineered systems, where drug toxicity, metabolism, interaction and/or efficacy can be determined |
| 01/26/2006 | US20060019325 Screening assay |
| 01/26/2006 | US20060019324 PknB kinase and pstP phosphatase and methods of identifying inhibitory substances |
| 01/26/2006 | US20060019318 Conformational and topological protein regulation |
| 01/26/2006 | US20060019306 Use of a gene expressed by fungal cells producing ochratoxin A in the detection and/or identification of ochratoxigenic fungi; Aspergillus ochraceus |
| 01/26/2006 | US20060019305 Diagnosis and treatment of PTP related disorders |
| 01/26/2006 | US20060019304 Simultaneous analysis of multiple genomes |
| 01/26/2006 | US20060019303 Method to identify and analyze genes having modified expression in stimulated T cells |
| 01/26/2006 | US20060019302 contacting a biological sample with a solution comprising moving a curved surface wetted with a solution in proximity to the biological sample whereby the distance separating the wetted curved surface and the sample is sufficient to form a moving liquid meniscus layer between the two |
| 01/26/2006 | US20060019301 Methods of producing mutant polynucleotides |